Foghorn Therapeutics, Inc. (FHTX)
1.87
-0.04
(-1.84%)
USD |
NASDAQ |
Nov 06, 16:00
1.865
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Market Cap : 109.80M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 109.80M |
| November 05, 2026 | 111.85M |
| November 04, 2026 | 123.30M |
| November 03, 2026 | 125.06M |
| November 02, 2026 | 125.06M |
| October 30, 2026 | 122.13M |
| October 29, 2026 | 122.71M |
| October 28, 2026 | 125.06M |
| October 27, 2026 | 120.36M |
| October 26, 2026 | 120.36M |
| October 23, 2026 | 117.43M |
| October 22, 2026 | 118.02M |
| October 21, 2026 | 119.78M |
| October 20, 2026 | 118.02M |
| October 19, 2026 | 109.80M |
| October 16, 2026 | 108.62M |
| October 15, 2026 | 110.97M |
| October 14, 2026 | 108.62M |
| October 13, 2026 | 108.62M |
| October 12, 2026 | 114.49M |
| October 09, 2026 | 117.43M |
| October 08, 2026 | 116.84M |
| October 07, 2026 | 122.71M |
| October 06, 2026 | 115.67M |
| October 05, 2026 | 117.43M |
| Date | Value |
|---|---|
| October 02, 2026 | 118.60M |
| October 01, 2026 | 171.45M |
| September 30, 2026 | 209.61M |
| September 29, 2026 | 206.67M |
| September 28, 2026 | 206.67M |
| September 25, 2026 | 205.50M |
| September 24, 2026 | 211.37M |
| September 23, 2026 | 227.22M |
| September 22, 2026 | 248.95M |
| September 21, 2026 | 243.66M |
| September 18, 2026 | 243.08M |
| September 17, 2026 | 246.60M |
| September 16, 2026 | 244.84M |
| September 15, 2026 | 241.90M |
| September 14, 2026 | 255.99M |
| September 11, 2026 | 259.52M |
| September 10, 2026 | 263.63M |
| September 09, 2026 | 274.20M |
| September 08, 2026 | 283.59M |
| September 04, 2026 | 288.87M |
| September 03, 2026 | 285.94M |
| September 02, 2026 | 303.55M |
| September 01, 2026 | 334.08M |
| August 31, 2026 | 337.02M |
| August 28, 2026 | 352.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anavex Life Sciences Corp. | 106.60M |
| Vaxcyte, Inc. | 9.539B |
| Connect Biopharma Holdings Ltd. | 45.89M |
| Caribou Biosciences, Inc. | 47.56M |
| Arrowhead Pharmaceuticals, Inc. | 8.208B |
Market Cap Related Metrics
| PS Ratio | 3.307 |
| Price | 1.87 |
| Earnings Yield | -54.62% |